doi: 10.1039/C8MT00182K 244 SarmaB
Long-term studies, such as the SUSTAIN-6 trial, have shown positive cardiovascular outcomes, suggesting that semaglutide may reduce the risk of major adverse cardiovascular events
Furthermore, pro-inflammatory and pro-fibrotic cytokines, including activin A, visfatin, transforming growth factor-1 (TGF-1), and MCP-1, promote fibroblast proliferation and myofibroblast activation, resulting in atrial and ventricular arrhythmias (103)
Who Our GLP-1 Provider Network Is For This partnership is designed for wellness professionals who want to offer GLP-1 support programs without becoming prescribers themselves, including: Weight loss & wellness coaches offering GLP-1 coaching and follow-up care Med-spas and body contouring studios in all 50 states Fitness trainers and nutrition coaches wanting Semaglutide and Tirzepatide support pathways for clients Online wellness brands that need a safe, compliant way to connect clients to GLP-1 provider networks Clinics seeking structured GLP-1 education , client onboarding, and metabolic coaching frameworks What You Can Offer Through the Network Physician-Supervised GLP-1 Support Through our approved GLP-1 provider network and telehealth partners, your clients can be evaluated by licensed prescribers for: GLP-1 medications such as Semaglutide and FDA-approved formulations like Wegovy Dual GLP-1/GIP medications such as Tirzepatide and approved formulations like Ozempic or related brands when medically appropriate Ongoing medical supervision, dosage decisions, and refill management Nice & Trim does not prescribe or dispense medications
Many are sold for laboratory research purposes only use for cosmetic, performance, or therapeutic applications is considered off-label and unregulated
With a high number lost from the placebo group I suspect it was largely due to people not seeing the results they wanted or noting no benefit in terms of appetite reduction thereby informing them they were likely getting the placebo
